Prothena Corp Public (PRTA) FCF Margin (QoQ) (2012 - 2026)

Prothena Corp Public (PRTA) FCF Margin (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Prothena Corp Public 458.13 Mn 128.67 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 11.11 Mn
Dec 31, 2025 -10.93 Mn
Sep 30, 2025 -62,976.00
Jun 30, 2025 83,808.00
Mar 31, 2025 36,380.00
Dec 31, 2024 240,704.00
Sep 30, 2024 -467,126.00
Jun 30, 2024 14.63 Mn
Mar 31, 2024 -12.97 Mn
Dec 31, 2023 -1.67 Mn
Sep 30, 2023 114,774.00
Jun 30, 2023 105,318.00
Mar 31, 2023 -217,996.00
Dec 31, 2022 205,282.00
Sep 30, 2022 63,691.00
Jun 30, 2022 54,692.00
Mar 31, 2022 -130,349.00
Dec 31, 2021 -202,383.00
Sep 30, 2021 1,944.00
Jun 30, 2021 2.11 Mn